Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort
癌症预防研究 3 队列中的环境化学物质负担和潜在乳腺癌风险
基本信息
- 批准号:10669253
- 负责人:
- 金额:$ 65.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-20 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAccelerationAddressAge YearsAgingAmerican Cancer SocietyAnimalsBiologicalBloodBlood BanksBlood specimenBody BurdenBreastBreast Cancer Risk FactorBreast Cancer cell lineBreast Epithelial CellsCancer ControlCancer EtiologyCarcinogenicity TestsCase/Control StudiesCellsChemical ExposureChemicalsCytokeratinDNA MethylationDataDevelopmentDiagnosisEndocrineEndocrine DisruptorsEnrollmentEnvironmental ExposureEnvironmental PollutantsEpithelial CellsEpitheliumEtiologyExposure toFemaleFoundationsFutureGenetic TranscriptionGenomeGenomicsGoalsHealthHormonesHumanLinkMalignant NeoplasmsMammary NeoplasmsMammary glandMeasurementMeasuresMethodologyMethylationMolecularMusMyoepithelial cellOutcomeParticipantPerimenopausePlasmaPoly-fluoroalkyl substancesPredispositionPrevention strategyProspective StudiesProteinsResearchResearch Project GrantsRiskRisk FactorsRoleSamplingSeminalSystemTestingTissuesUnited States Environmental Protection AgencyWomanWorkage relatedagedbead chipbreast cancer diagnosiscancer diagnosiscancer initiationcancer preventioncancer riskcancer subtypescarcinogenicitycase controlcohortdesignenvironmental chemicalepidemiology studyepigenome-wide association studiesin vivoinnovationinsightinterdisciplinary approachinterestmalignant breast neoplasmmammarymammary epitheliummethylomemultidisciplinarypolybrominated diphenyl etherprospectivestem cells
项目摘要
Today there are more than 85,000 EPA-registered synthetic chemicals, but only 10% have been tested for
carcinogenicity in animal studies. Of those tested, ~200 have shown evidence of causing cancer and/or an
increase in mammary tumors. However, few of the chemicals have been evaluated in human studies, and results
in humans have been inconclusive. Our study will focus on chemical body burden of per- and poly-fluoroalkyl
substances (PFAS), and concomitant risk of developing invasive breast cancer during the menopausal transition.
These “forever chemicals” are pervasive, enduring, and of high public interest, yet studies of their possible
relationship to breast cancer have been limited. We hypothesize that elevated body-burden levels of these
endocrine-disrupting chemicals (EDCs) will increase the risk of developing invasive breast cancer, and that
alterations in DNA methylation (DNAm) and the breast microenvironment are mechanisms that link these
chemical exposures and breast cancer. We will test this hypothesis using a three-pronged approach. In Specific
Aim 1, we will conduct a prospective study of women in the American Cancer Society Cancer Prevention Study-3
(CPS-3) to assess the association between body burden of PFAS during the menopausal transition and
subsequent development of invasive breast cancer. We will measure PFAS levels in plasma samples collected
1 to 7 years before invasive breast cancer diagnosis in 1000 CPS-3 participants and 1000 matched, cancer-free
CPS-3 participants, all between 40 and 57 years of age at blood draw. In Specific Aim 2, studying the same
participants, we will measure DNAm using Infinium MethylationEPIC BeadChips and conduct an epigenome-
wide association study (EWAS) to identify DNAm changes associated with levels of PFAS in the cancer-free
participants. We then will determine the association between the PFAS-associated DNAm changes and risk of
developing breast cancer. This valuable DNAm data also can be used later for other outcomes, including
exposure to other EDCs. In Specific Aim 3, we will determine the direct effects of PFAS on tissue- and molecular-
level states associated with susceptibility to cancer initiation in genomically-well-characterized primary human
breast mammary epithelial cells (HMECs). Identifying these mechanisms in primary breast cells is critically
important, as PFAS mechanisms of action generally differ by tissue. We will use 2-D cultures to determine the
effects of short-term exposures and 3-D cultures to define the effects of protracted chemical exposures on
changes in epithelial lineage consistent with accelerated aging and age-related molecular changes in genome
methylation, lineage-specific transcription, and cytokeratin proteins. Results from this multi-disciplinary approach
will advance our understanding of the effects of PFAS exposures on risk of developing breast cancer during an
important window of susceptibility. Ultimately, we hope results from our proposed project will identify an
integrated biological signature of environmental exposure, deliver mechanistic insights into breast cancer
development from EDCs, and inform future studies for prevention strategies to reduce or mitigate exposures.
今天,美国环保署注册的合成化学品超过85,000种,但只有10%经过检测。
动物研究中的致癌性。在接受测试的人中,约200人显示出致癌和/或
乳腺肿瘤增加。然而,很少有化学物质在人类研究中进行评估,结果
在人类中的应用还没有定论。我们的研究将集中在全氟烷基和多氟烷基的化学体内负荷
物质(PFAS),以及绝经过渡期发生浸润性乳腺癌的伴随风险。
这些“永久性化学物质”普遍存在,持久存在,并且具有很高的公众利益,但对它们可能存在的研究
与乳腺癌的关系有限。我们假设这些物质的体内负荷水平升高
内分泌干扰物(EDCs)会增加患浸润性乳腺癌的风险,
DNA甲基化(DNAm)和乳腺微环境的改变是将这些联系起来的机制。
化学品暴露和乳腺癌。我们将使用三管齐下的方法来检验这一假设。在特定
目标1,我们将在美国癌症协会癌症预防研究-3中对女性进行前瞻性研究
(CPS-3)评估绝经过渡期PFAS的身体负荷与
随后发生浸润性乳腺癌我们将测量采集的血浆样本中的PFAS水平
在1000名CPS-3参与者和1000名匹配的无癌症患者中,浸润性乳腺癌诊断前1至7年
CPS-3参与者,抽血时年龄均在40至57岁之间。在具体目标2中,
参与者,我们将使用Infinium MethylationEPIC BeadChips测量DNAm并进行表观基因组-
广泛关联研究(EWAS),以确定与无癌组织中PFAS水平相关的DNA变化。
参与者然后,我们将确定PFAS相关的DNAm变化与以下风险之间的关联:
患上了乳腺癌这些有价值的DNAm数据也可以用于其他结果,包括
暴露于其他EDCs。在具体目标3中,我们将确定PFAS对组织和分子的直接影响,
与基因组学良好表征的原发性人类中癌症起始易感性相关的水平状态
乳腺上皮细胞(HMEC)。在原代乳腺细胞中识别这些机制至关重要
重要的是,PFAS的作用机制通常因组织而异。我们将使用二维培养来确定
短期接触和三维培养的影响,以确定长期化学品接触对
上皮细胞谱系的变化与加速老化和基因组中与年龄相关的分子变化一致
甲基化、谱系特异性转录和细胞角蛋白。这种多学科方法的结果
将促进我们对PFAS暴露对乳腺癌风险影响的理解,
敏感性的重要窗口。最终,我们希望我们所提出的项目的结果将确定一个
环境暴露的综合生物特征,提供对乳腺癌的机制见解
从内分泌干扰物的发展,并为未来的预防策略,以减少或减轻暴露的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan L. Neuhausen其他文献
Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant
BRCA1 致病性变异女性的奇偶性、母乳喂养与早发性乳腺癌风险
- DOI:
10.1038/s41416-025-03029-x - 发表时间:
2025-05-02 - 期刊:
- 影响因子:6.800
- 作者:
Joanne Kotsopoulos;Christopher A. Maxwell;Jan Lubinski;Tomasz Huzarski;Raymond H. Kim;Nadine Tung;Andrea Eisen;William Foulkes;Amber Aeilts;Susan L. Neuhausen;Louise Bordeleau;Rama Khokha;Tuya Pal;Beth Karlan;Robert Fruscio;Fergus Couch;Ping Sun;Jacek Gronwald;Steven A. Narod - 通讯作者:
Steven A. Narod
Contraceptive use and the risk of ovarian cancer among women with a emBRCA1/em or emBRCA2/em mutation
- DOI:
10.1016/j.ygyno.2022.01.014 - 发表时间:
2022-03-01 - 期刊:
- 影响因子:4.100
- 作者:
Yue Yin Xia;Jacek Gronwald;Beth Karlan;Jan Lubinski;Jeanna M. McCuaig;Jennifer Brooks;Pal Moller;Andrea Eisen;Sophie Sun;Leigha Senter;Louise Bordeleau;Susan L. Neuhausen;Christian F. Singer;Nadine Tung;William D. Foulkes;Ping Sun;Steven A. Narod;Joanne Kotsopoulos;Rinat Yerushalmi;Robert Fruscio;Stephanie Cohen - 通讯作者:
Stephanie Cohen
Susan L. Neuhausen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan L. Neuhausen', 18)}}的其他基金
Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort
癌症预防研究 3 队列中的环境化学物质负担和潜在乳腺癌风险
- 批准号:
10525499 - 财政年份:2022
- 资助金额:
$ 65.67万 - 项目类别:
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas
拉丁裔乳腺癌的种系和肿瘤基因组分析
- 批准号:
8673705 - 财政年份:2014
- 资助金额:
$ 65.67万 - 项目类别:
Celiac Disease: From Genetic Risk to Disease Development
乳糜泻:从遗传风险到疾病发展
- 批准号:
7591126 - 财政年份:2008
- 资助金额:
$ 65.67万 - 项目类别:
Celiac Disease: From Genetic Risk to Disease Development
乳糜泻:从遗传风险到疾病发展
- 批准号:
8068619 - 财政年份:2008
- 资助金额:
$ 65.67万 - 项目类别:
Celiac Disease: From Genetic Risk to Disease Development
乳糜泻:从遗传风险到疾病发展
- 批准号:
7371748 - 财政年份:2008
- 资助金额:
$ 65.67万 - 项目类别:
The IGF Signaling Pathway and Breast Cancer Risk
IGF 信号通路与乳腺癌风险
- 批准号:
7579023 - 财政年份:2007
- 资助金额:
$ 65.67万 - 项目类别:
The IGF Signaling Pathway and Breast Cancer Risk
IGF 信号通路与乳腺癌风险
- 批准号:
7777345 - 财政年份:2007
- 资助金额:
$ 65.67万 - 项目类别:
The IGF Signaling Pathway and Breast Cancer Risk
IGF 信号通路与乳腺癌风险
- 批准号:
7373525 - 财政年份:2007
- 资助金额:
$ 65.67万 - 项目类别:
The IGF Signaling Pathway and Breast Cancer Risk
IGF 信号通路与乳腺癌风险
- 批准号:
7213798 - 财政年份:2007
- 资助金额:
$ 65.67万 - 项目类别:
GENETIC EPIDEMIOLOGY OF BREAST CANCER--BRCA1 AND BRCA2
乳腺癌的遗传流行病学--BRCA1和BRCA2
- 批准号:
6164238 - 财政年份:1998
- 资助金额:
$ 65.67万 - 项目类别:
相似海外基金
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
- 批准号:
NE/Y000080/1 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Research Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328975 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Continuing Grant
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
- 批准号:
2400967 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Standard Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
- 批准号:
10112700 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328973 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328972 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328974 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332916 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332917 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Standard Grant
Study of the Particle Acceleration and Transport in PWN through X-ray Spectro-polarimetry and GeV Gamma-ray Observtions
通过 X 射线光谱偏振法和 GeV 伽马射线观测研究 PWN 中的粒子加速和输运
- 批准号:
23H01186 - 财政年份:2023
- 资助金额:
$ 65.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)